Filtros de búsqueda

Lista de obras de Niklas Mattsson

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

artículo científico publicado en 2017

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease

artículo científico publicado en 2017

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

artículo científico publicado en 2016

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

scholarly article by Sebastian Palmqvist et al published 23 October 2018 in Alzheimer's and Dementia

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

artículo científico publicado en 2012

Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome

artículo científico publicado en 2014

Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications

artículo científico publicado en 2009

Amyloid biomarkers in Alzheimer's disease

artículo científico publicado en 2015

Amyloid pathology in the progression to mild cognitive impairment

artículo científico publicado en 2017

Amyloid-β metabolism in Niemann-Pick C disease models and patients

artículo científico publicado en 2012

An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid

artículo científico publicado en 2012

Apathy and anxiety are early markers of Alzheimer's disease

artículo científico publicado en 2019

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

artículo científico publicado en 2014

Apolipoprotein E genotypes and longevity across dementia disorders.

artículo científico publicado en 2018

Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information

artículo científico publicado en 2016

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms

artículo científico publicado en 2014

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

scientific article published on 01 July 2019

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

artículo científico publicado en 2017

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

artículo científico publicado en 2015

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

artículo científico publicado en 2017

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment

artículo científico publicado en 2014

Association of enlarged perivascular spaces and measures of small vessel and Alzheimers disease

artículo científico publicado en 2020

Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults

scientific article published on 22 July 2019

Associations between partial pressure of oxygen and neurological outcome in out-of-hospital cardiac arrest patients: an explorative analysis of a randomized trial

scientific article published on 28 January 2019

Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease

Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections

artículo científico publicado en 2013

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease

scientific article published on 15 April 2020

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system

artículo científico publicado en 2012

Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem

artículo científico publicado en 2015

Bidirectional links between Alzheimer's disease and Niemann-Pick type C disease

artículo científico publicado en 2014

Biochemical markers in Alzheimer's disease clinical trials

artículo científico publicado en 2010

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease

artículo científico publicado en 2015

Biomarkers for microglial activation in Alzheimer's disease

artículo científico publicado en 2011

Biomarkers for tau pathology.

artículo científico publicado en 2018

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

artículo científico publicado en 2020

Brain structure and function as mediators of the effects of amyloid on memory

artículo científico publicado en 2015

CDH6 and HAGH protein levels in plasma associate with Alzheimer's disease in APOE ε4 carriers

scientific article published on 19 May 2020

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

artículo científico publicado en 2016

CSF biomarker variability in the Alzheimer's Association quality control program

artículo científico publicado en 2013

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

artículo científico publicado en 2009

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.

artículo científico publicado en 2013

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.

artículo científico publicado en 2015

CSF biomarkers in neurodegenerative diseases.

scientific article published on 09 February 2011

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease

CSF biomarkers: pinpointing Alzheimer pathogenesis

scientific article published on October 2009

CSF in Alzheimer's disease.

artículo científico publicado en 2014

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

artículo científico publicado en 2014

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders

artículo científico publicado en 2013

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients

artículo científico

Carbon dioxide dynamics in relation to neurological outcome in resuscitated out-of-hospital cardiac arrest patients: an exploratory Target Temperature Management Trial substudy

artículo científico publicado en 2018

Cerebral amyloid burden and Alzheimer's disease subtypes--does localization information matter?

artículo científico publicado en 2015

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

artículo científico publicado en 2013

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

artículo científico publicado en 2013

Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?

artículo científico publicado en 2013

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography

artículo científico publicado en 2016

Cerebrospinal fluid analysis should be considered in patients with cognitive problems

artículo científico publicado en 2010

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

scientific article published on 11 November 2019

Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease

artículo científico publicado en 2015

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples

scientific article published on 14 October 2013

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

artículo científico publicado en 2011

Cerebrospinal fluid biomarkers in neurological diseases in children

artículo científico

Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.

artículo científico publicado en 2013

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

scientific article published on 15 October 2012

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study

artículo científico publicado en 2013

Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis

artículo científico publicado en 2007

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

artículo científico publicado en 2011

Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival

artículo científico publicado en 2017

Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients

scientific article published on 09 July 2018

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

artículo científico publicado en 2015

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease

scientific article published on 03 April 2020

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease

artículo científico publicado en 2012

Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia

artículo científico publicado en 2015

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

scientific article published on 17 August 2016

Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease

artículo científico publicado en 2015

Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia

artículo científico publicado en 2015

Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment

artículo científico publicado en 2018

Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

artículo científico publicado en 2017

Coagulation of cerebrospinal fluid--the Nonne-Froin sign.

artículo científico publicado en 2013

Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment

artículo científico publicado en 2016

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

artículo científico publicado en 2018

Converging molecular pathways in human neural development and degeneration

artículo científico publicado en 2009

Converging pathways of chromogranin and amyloid metabolism in the brain

artículo científico publicado en 2010

Correction to: Relevance of biomarkers across different neurodegenerative diseases

artículo científico publicado en 2020

Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression

artículo científico publicado en 2017

Data-driven approaches for Tau-PET imaging biomarkers in Alzheimer's disease

scholarly article published 11 January 2018

Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease

scholarly article by Jacob W Vogel et al published 19 October 2018 in Human Brain Mapping

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

artículo científico publicado en 2015

Determining clinically meaningful decline in preclinical Alzheimer disease

scientific article published on 09 July 2019

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges

artículo científico

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

artículo científico publicado en 2019

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

artículo científico publicado en 2014

Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry

artículo científico publicado en 2014

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.

artículo científico publicado en 2006

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders

artículo científico publicado en 2018

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases

artículo científico publicado en 2011

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

artículo científico publicado en 2017

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

scientific article published on 11 July 2018

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease

artículo científico publicado en 2013

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

artículo científico publicado en 2013

Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study

artículo científico publicado en 2017

Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients

artículo científico publicado en 2006

Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis

artículo científico publicado en 2008

Emerging β-amyloid pathology and accelerated cortical atrophy

artículo científico publicado en 2014

Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway

artículo científico publicado en 2017

Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid

artículo científico publicado en 2014

Future screening for incipient Alzheimer's disease--the influence of prevalence on test performance

artículo científico publicado en 2009

Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study

artículo científico publicado en 2010

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium

artículo científico publicado en 2012

Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study

scholarly article by Niklas Mattsson et al published 7 August 2018 in Alzheimers Research & Therapy

History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress

artículo científico publicado en 2014

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

artículo científico publicado en 2016

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

scientific article published on 07 December 2020

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

artículo científico publicado en 2014

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

artículo científico publicado en 2010

Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders

artículo científico

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

artículo científico publicado en 2007

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease

artículo científico publicado en 2010

Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study

artículo científico publicado en 2011

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment

artículo científico publicado en 2012

Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease

artículo científico publicado en 2013

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

artículo científico publicado en 2015

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease

artículo científico publicado en 2013

Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.

artículo científico publicado en 2011

Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women

scholarly article by Per Johansson et al published 5 August 2011 in Clinical Endocrinology

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development

artículo científico publicado en 2016

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

artículo científico publicado en 2010

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

artículo científico publicado en 2011

Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.

artículo científico publicado en 2008

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS

artículo científico publicado en 2012

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status

scientific article published on 24 June 2019

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg

artículo científico publicado en 2020

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

artículo científico publicado en 2022

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia

artículo científico publicado en 2020

Plasma amyloid-β in patients with Tangier disease

artículo científico publicado en 2013

Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease

scientific article published on 29 November 2020

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

artículo científico publicado en 2017

Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls

artículo científico publicado en 2015

Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease

artículo científico publicado en 2019

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

artículo científico publicado en 2018

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

artículo científico publicado en 2015

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

artículo científico publicado en 2018

Primary fatty amides are potential plasma biomarkers for AD

scientific article published on 01 September 2019

Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

artículo científico publicado en 2012

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

artículo científico publicado en 2010

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

artículo científico publicado en 2021

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

artículo científico publicado en 2009

Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease

artículo científico publicado en 2012

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

artículo científico

Relevance of biomarkers across different neurodegenerative

scientific article published on 13 May 2020

Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?

artículo científico publicado en 2016

Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative

artículo científico publicado en 2014

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

artículo científico publicado en 2015

Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease

artículo científico publicado en 2016

Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest

artículo científico publicado en 2019

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

articulo cientifico

Serum levels of LIGHT in MS

article by Clas Malmeström et al published 4 October 2012 in Multiple Sclerosis Journal

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

artículo científico publicado en 2016

Serum tau and neurological outcome in cardiac arrest.

artículo científico publicado en 2017

Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest

artículo científico publicado en 2019

Serum visinin-like protein-1 in concussed professional ice hockey players

artículo científico publicado en 2015

Smoking and increased Alzheimer's disease risk: a review of potential mechanisms

artículo científico publicado en 2014

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

artículo científico publicado en 2017

The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients.

artículo científico publicado en 2012

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis

artículo científico publicado en 2011

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

artículo científico publicado en 2018

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

artículo científico publicado en 2014

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

scientific article published on 23 June 2018

The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis

artículo científico publicado en 2013

The transitional association between β-amyloid pathology and regional brain atrophy

artículo científico publicado en 2014

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease

artículo científico publicado en 2017

To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease

artículo científico publicado en 2010

Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair

artículo científico publicado en 2015

Understanding the cause of sporadic Alzheimer's disease

artículo científico publicado en 2014

Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease

artículo científico publicado en 2010

What is a certified reference material?

artículo científico publicado en 2012

[Niemann-Pick type C disease. Rare but possible diagnosis in adult neurology and psychiatry].

artículo científico publicado en 2013

β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly

artículo científico publicado en 2019

β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda